ClinicalTrials.gov
public full text
Public Domain
Use of Tinzaparin for Anticoagulation in Hemodialysis
The HEMO-TIN trial is designed to look at both the safety (bleeding risk) and effectiveness (clotting risk) of tinzaparin compared with unfractionated heparin for anticoagulation in hemodialysis patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer#843519
- The optimal vascular access for haemodialysis remains elusive.#469556
- Tinzaparin in the Treatment of the Acute Pulmonary Embolism#852239
- Hemodialysis Adequacy Using a Heparin-grafted Dialyzer and a Citrate-enriched Dialysate#854340
- HEParin Antagonisation in Transcatheter Aortic Valve Implantation#895635
Record · ID 800733
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive